BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meijide H, Pértega S, Rodríguez-Osorio I, Castro-Iglesias Á, Baliñas J, Rodríguez-Martínez G, Mena Á, Poveda E. Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected. AIDS 2017;31:1099-107. [PMID: 28441174 DOI: 10.1097/QAD.0000000000001448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Zhang R, Ding X, Jin Y, Qin R, Xia B, Liao Q, Hu H, Song W, Wang Z, Zhang X, Xu J. Pathologically complete remission to combination of invariant NK T cells and anti-CD20 antibody in a refractory HIV+ diffuse large B-cell lymphoma patient. Immunotherapy 2022. [PMID: 35443802 DOI: 10.2217/imt-2021-0247] [Reference Citation Analysis]
2 Ousley J, Nesbitt R, Kyaw NTT, Bermudez E, Soe KP, Anicete R, Mon PE, Le Shwe Sin Ei W, Christofani S, Fernandez M, Ciglenecki I. Increased hepatitis C virus co-infection and injection drug use in HIV-infected fishermen in Myanmar. BMC Infect Dis 2018;18:657. [PMID: 30547747 DOI: 10.1186/s12879-018-3558-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Noy A. Optimizing treatment of HIV-associated lymphoma. Blood 2019;134:1385-94. [PMID: 30992269 DOI: 10.1182/blood-2018-01-791400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
4 Nkwonta CA, Zhang J, Chen S, Weissman S, Olatosi B, Li X. Prevalence and trend of AIDS-defining cancers and non-AIDS-defining cancers and their association with antiretroviral therapy among people living with HIV in South Carolina: a population-based cohort study. AIDS Care. [DOI: 10.1080/09540121.2022.2074957] [Reference Citation Analysis]
5 Willis SJ, Kim HN, Achenbach CJ, Cachay ER, Christopoulos KA, Crane HM, Franco RA, Hurt CB, Kitahata MM, Moore RD, Silverberg MJ, Tien PC, Westreich D, Marcus JL. Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV. HIV Med 2021. [PMID: 34951105 DOI: 10.1111/hiv.13218] [Reference Citation Analysis]
6 Trickey A, May MT, Gill MJ, Grabar S, Vehreschild J, Wit FWNM, Bonnet F, Cavassini M, Abgrall S, Berenguer J, Wyen C, Reiss P, Grabmeier-Pfistershammer K, Guest JL, Shepherd L, Teira R, d'Arminio Monforte A, Del Amo J, Justice A, Costagliola D, Sterne JAC. Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies. Int J Cancer 2020;146:3134-46. [PMID: 32003460 DOI: 10.1002/ijc.32895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Billa O, Chalouni M, Salmon D, Poizot-Martin I, Gilbert C, Katlama C, Neau D, Chas J, Morlat P, Lacombe K, Naqvi A, Barange K, Gervais A, Bouchaud O, Rosenthal E, Lascoux-Combe C, Garipuy D, Alric L, Dominguez S, Vittecoq D, Goujard C, Duvivier C, Aumaitre H, Miailhes P, Zucman D, Simon A, Lazaro E, Raffi F, Esterle L, Wittkop L, Bani-Sadr F; ANRS CO13 HEPAVIH Study Group. Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort. PLoS One 2018;13:e0208657. [PMID: 30562358 DOI: 10.1371/journal.pone.0208657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Golemis EA, Scheet P, Beck TN, Scolnick EM, Hunter DJ, Hawk E, Hopkins N. Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev 2018;32:868-902. [PMID: 29945886 DOI: 10.1101/gad.314849.118] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]